BeStock  
Stocks › TGTX

TG Therapeutics TGTX

US equityMarket cap rank #1443
$63.34 −$1.54 (-2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $63.21 -0.21%
Open$64.10
Prev close$64.88
Day range$63.12 – $65.64
Volume2.09M
Market cap$9.57B
P/E (TTM)94.5
Dividend yield–

Earnings

Average move on report day±16.7%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+30.9%
Worst reaction-49.3%

Stock move on the day after each report

+26.7%2023/Q4+16.3%2024/Q1+19.6%2024/Q2-9.4%2024/Q3+14.4%2024/Q4-13.3%2025/Q1-18.0%2025/Q2-3.1%2025/Q3+4.2%2025/Q4+16.3%2026/Q1-11.3%2026/Q2+5.9%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q39 Nov 2026Pre Market±10.2%+5.94%Within range
2026/Q23 Aug 2026Pre Market±11.7%-11.26%Within range
2026/Q16 May 2026Pre Market±8.8%+16.26%Bigger than priced
2025/Q426 Feb 2026Pre Market±10.5%+4.18%Within range
2025/Q33 Nov 2025Pre Market±14.5%-3.13%Within range
2025/Q24 Aug 2025Pre Market±14.6%-17.99%Bigger than priced
2025/Q15 May 2025None±13.8%-13.26%Within range
2024/Q43 Mar 2025None±13.2%+14.39%Bigger than priced
2024/Q34 Nov 2024Pre Market±17.9%-9.44%Within range
2024/Q26 Aug 2024Pre Market±23.0%+19.58%Within range
2024/Q11 May 2024Pre Market±8.8%+16.25%Bigger than priced
2023/Q428 Feb 2024Pre Market±17.6%+26.74%Bigger than priced
2023/Q31 Nov 2023Pre Market±16.4%+30.92%Bigger than priced
2023/Q21 Aug 2023Pre Market±21.7%-49.30%Bigger than priced
2023/Q11 May 2023Pre Market±11.7%+23.40%Bigger than priced
2022/Q428 Feb 2023After Market±5.9%-4.37%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$259.94M+60.7% YoY
Operating profit$85.90M+192.5% YoY
Net profit$55.46M-85.8% YoY
Diluted EPS$0.35-85.6% YoY
Free cash flow$44.95M+293.5% YoY
Operating cash flow$45.23M

Revenue, last 8 quarters

$108.2MDec '24$120.9MMar '25$141.1MJun '25$161.7MSep '25$192.6MDec '25$204.9MMar '26$240.3MJun '26$259.9MSep '26

Net profit, last 8 quarters

$23.3MDec '24$5.1MMar '25$28.2MJun '25$390.9MSep '25$23.0MDec '25$19.8MMar '26$7.8MJun '26$55.5MSep '26

Profitability & balance sheet

Gross margin82.7%
Operating margin21.5%
Net margin11.8%
Return on equity18.0%
Return on assets8.1%
Return on invested capital12.7%
Current ratio4.50
Liabilities / assets64.1%
Cash & investments$504.67M
Total debt$752.53M
Net cash (debt)-$247.86M
Free cash flow / sales9.5%

Discussion

No comments yet — be the first to weigh in on TGTX.

Sign in to join the discussion.

Scroll to Top